- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/32 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products from oncogenes
Patent holdings for IPC class C07K 16/32
Total number of patents in this class: 4308
10-year publication summary
|
403
|
339
|
353
|
368
|
398
|
379
|
356
|
366
|
376
|
197
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 4104 |
164 |
| Hoffmann-La Roche Inc. | 3793 |
118 |
| F. Hoffmann-La Roche AG | 7837 |
82 |
| Daiichi Sankyo Company, Limited | 1890 |
51 |
| Zymeworks Inc. | 253 |
50 |
| Mayo Foundation for Medical Education and Research | 3382 |
47 |
| Merus N.V. | 191 |
45 |
| Genmab A/S | 474 |
45 |
| The Trustees of the University of Pennsylvania | 4415 |
43 |
| Regeneron Pharmaceuticals, Inc. | 4701 |
41 |
| Sanofi | 4301 |
41 |
| Amgen Inc. | 4427 |
40 |
| Memorial Sloan-Kettering Cancer Center | 2043 |
40 |
| Centre National de La Recherche Scientifique | 11023 |
34 |
| Sutro Biopharma, Inc. | 184 |
33 |
| Novartis AG | 10262 |
28 |
| Board of Regents, The University of Texas System | 6107 |
28 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3335 |
27 |
| Ablynx N.V. | 426 |
26 |
| Immatics Biotechnologies GmbH | 1127 |
25 |
| Other owners | 3300 |